Abstract
Speech brain-machine interfaces (BMI’s) translate brain signals into words or audio outputs, enabling communication for people having lost their speech abilities due to diseases or injury. While important advances in vocalized, attempted, and mimed speech decoding have been achieved, results for internal speech decoding are sparse, and have yet to achieve high functionality. Notably, it is still unclear from which brain areas internal speech can be decoded. In this work, a tetraplegic participant with implanted microelectrode arrays located in the supramarginal gyrus (SMG) and primary somatosensory cortex (S1) performed internal and vocalized speech of six words and two pseudowords. We found robust internal speech decoding from SMG single neuron activity, achieving up to 91% classification accuracy during an online task (chance level 12.5%). Evidence of shared neural representations between internal speech, word reading, and vocalized speech processes were found. SMG represented words in different languages (English/ Spanish) as well as pseudowords, providing evidence for phonetic encoding. Furthermore, our decoder achieved high classification with multiple internal speech strategies (auditory imagination/ visual imagination). Activity in S1 was modulated by vocalized but not internal speech, suggesting no articulator movements of the vocal tract occurred during internal speech production. This works represents the first proof-of-concept for a high-performance internal speech BMI.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01964261
Funding Statement
This research was supported by the NIH National Institute of Neurological Disorders and Stroke Grant U01: U01NS098975 and U01: U01NS123127 (S.K.W, D.B., K.P., C.L. and R.A.A.), and by the T&C Chen Brain-machine Interface center (S.K.W., D.B., R.A.A.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Internal Review Board of California Institute of Technology gave ethical approval for this work on 7/25/2022.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
